Skip to search formSkip to main contentSkip to account menu

Nebido

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

testosterone undecanoate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cryptozoospermia after treatment with clomiphene citrate following long-term use of intramuscular testosterone undecanoate depot injection (Nebido®)
Abstract Objective To illustrate the importance of treatment duration with intramuscular testosterone undecanoate (Nebido®) for… 
2013
2013
FDA declines approval of testosterone drug for third time.
2013
2013
UGT2B17 Genotype and the Pharmacokinetic Serum Profile of Testosterone during Substitution Therapy with Testosterone Undecanoate. A Retrospective Experience from 207 Men with Hypogonadism
Background: Testosterone (T) is mainly excreted in the urine as testosterone glucuronide (TG). This glucuronidation is partly… 
2013
2013
The use of drugs Impaza and Nebido in the treatment of erectile dysfunction in patients with type 2 diabetes mellitus of reproductive age.
The main objective of the study was to investigate the efficacy of using a mono and combined therapy drugs Impaza and Nebido for… 
2011
2011
Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually‐adjusted injection intervals
Study Type – Therapy (case series)
 Level of Evidence 4 
Review
2007
Review
2007
The latest options and future agents for treating male hypogonadism
Exogenous testosterone has long been used in medicine as a pharmaceutical agent. Its use in hypogonadism is well characterized… 
2007
2007
Plasma levels of dihydrotestosterone remain in the normal range in men treated with long‐acting parenteral testosterone undecanoate
The major goal of androgen therapy is to achieve testosterone levels as close to physiological concentrations as possible. For… 
2006
2006
Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9–12 February 2006…
This symposium report summarizes first extensive clinical findings with injectable testosterone undecanoate (Nebido®) in… 
2006
2006
Longterm experience of more than 8 years with a novel formulation of testosterone undecanoate (Nebido) in substitution therapy of hypogonadal men
Review
2005
Review
2005
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism
Over the last six decades, tremendous strides have been made in the development of safe, efficacious and ‘patient-friendly… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)